Discussion
An expanded access program (EAP) at Massachusetts General Hospital (MGH) shows that such programs can work, a study found. The program enabled 11 people with SOD1-associated amyotrophic lateral sclerosis (ALS) who could not participate in clinical trials to receive Qalsody (tofersen) before its U.S. approval. In addition, it…